Table 3.
Variables | Time of intervention | Acarbose group | Control group | P† |
---|---|---|---|---|
CRP | Before | 1.03±0.44 | 1.06±0.36 | 0.748 |
After | 0.43±0.26 | 0.93±0.38 | <0.001 | |
Change CRP | −0.60±0.47 | −0.14±0.42 | <0.001 | |
IMT | Before | 0.74±0.14 | 0.68±0.15 | 0.083 |
After | 0.49±0.40 | 0.67±0.16 | 0.009 | |
Change IMT | −0.24±0.39 | −0.01±0.06 | 0.001 | |
FMD | Before | 0.12±0.04 | 0.11±0.04 | 0.290 |
After | 0.10±0.06 | 0.10±0.05 | 1.00 | |
Change FMD | −0.02±0.05 | −0.01±0.04 | 0.371 | |
EFT | Before | 2.72±1.26 | 2.87±0.88 | 0.548 |
After | 1.83±0.68 | 2.45±0.62 | <0.001 | |
Change EFT | −0.89±0.83 | −0.43±0.64 | 0.046 |
Data shown mean±SD. CRP=C-reactive protein, FMD=Flow-mediated dilation, IMT=Intima-media thickness, EFT=Epicardial fat thickness. †Use of independent sample t-test for comparison of mean variables between two groups